Market Research

Anticoagulant Reversal Drugs Market by Product (Andexxa, Idarucizumab, Protamine), Distribution (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 192 Pages 360iResearch January, 2024 IRE18418397
Best Price Guarantee
Price from $4,749
Length 192 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18418397

Anticoagulant Reversal Drugs Market by Product (Andexxa, Idarucizumab, Protamine), Distribution (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030


The Anticoagulant Reversal Drugs Market size was estimated at USD 646.38 million in 2023 and expected to reach USD 725.40 million in 2024, at a CAGR 12.31% to reach USD 1,457.59 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticoagulant Reversal Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticoagulant Reversal Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticoagulant Reversal Drugs Market, highlighting leading vendors and their innovative profiles. These include Alexion Pharmaceuticals Inc., AMAG Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., AstraZeneca PLC, Bausch Health Companies, Inc., BioVascular Inc., Boehringer Ingelheim GmbH, Cadila Healthcare Limited, CSL Limited, Daiichi Sankyo Company, Limited, Dr Reddy’s Laboratories Ltd,, Eli Lilly and Company, Fresenius Kabi AG, Genentech, Inc., Hikma Pharmaceuticals PLC, Octapharma AG, Otsuka Pharmaceutical Co., Ltd., and Pfizer, Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoagulant Reversal Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Andexxa
  • Idarucizumab
  • Protamine
  • Tranexamic Acid
  • Vitamin K
  • Distribution

    Hospital Pharmacies
  • Retail Pharmacies
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Anticoagulant Reversal Drugs Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticoagulant Reversal Drugs Market?
    3. What are the technology trends and regulatory frameworks in the Anticoagulant Reversal Drugs Market?
    4. What is the market share of the leading vendors in the Anticoagulant Reversal Drugs Market?
    5. Which modes and strategic moves are suitable for entering the Anticoagulant Reversal Drugs Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Anticoagulant Reversal Drugs Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalence of bleeding disorders and anticoagulant therapies
    5.1.1.2. Growing number of product approvals worldwide
    5.1.1.3. Increasing incidence of unplanned surgeries
    5.1.2. Restraints
    5.1.2.1. High cost of the patent drugs
    5.1.3. Opportunities
    5.1.3.1. Improvements in reimbursement policies globally
    5.1.3.2. Ongoing research activities and funding to treat anticoagulant-related bleeds
    5.1.4. Challenges
    5.1.4.1. Stringent regulatory reforms due to severe risks associated with the reversal of anticoagulation
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Anticoagulant Reversal Drugs Market, by Product
    6.1. Introduction
    6.2. Andexxa
    6.3. Idarucizumab
    6.4. Protamine
    6.5. Tranexamic Acid
    6.6. Vitamin K
    7. Anticoagulant Reversal Drugs Market, by Distribution
    7.1. Introduction
    7.2. Hospital Pharmacies
    7.3. Retail Pharmacies
    8. Americas Anticoagulant Reversal Drugs Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Anticoagulant Reversal Drugs Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Anticoagulant Reversal Drugs Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. Alexion Pharmaceuticals Inc.
    12.1.2. AMAG Pharmaceuticals, Inc.
    12.1.3. Amneal Pharmaceuticals, Inc.
    12.1.4. AstraZeneca PLC
    12.1.5. Bausch Health Companies, Inc.
    12.1.6. BioVascular Inc.
    12.1.7. Boehringer Ingelheim GmbH
    12.1.8. Cadila Healthcare Limited
    12.1.9. CSL Limited
    12.1.10. Daiichi Sankyo Company, Limited
    12.1.11. Dr Reddy’s Laboratories Ltd,
    12.1.12. Eli Lilly and Company
    12.1.13. Fresenius Kabi AG
    12.1.14. Genentech, Inc.
    12.1.15. Hikma Pharmaceuticals PLC
    12.1.16. Octapharma AG
    12.1.17. Otsuka Pharmaceutical Co., Ltd.
    12.1.18. Pfizer, Inc.
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. ANTICOAGULANT REVERSAL DRUGS MARKET RESEARCH PROCESS
    FIGURE 2. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANTICOAGULANT REVERSAL DRUGS MARKET DYNAMICS
    FIGURE 7. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    FIGURE 8. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
    FIGURE 10. ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT REVERSAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ANTICOAGULANT REVERSAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. ANTICOAGULANT REVERSAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings